CME Group (CME) Earnings Analysis

CME Group (CME) next reports earnings on 2026-10-28, consensus EPS 2.93 USD. Last quarter (2026-07-22) it beat with EPS 2.99 USD vs 2.91 USD est (+2.7%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 21.03.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CME next report earnings?

Next earnings date2026-10-28
Consensus EPS estimate2.93 USD
Revenue estimate1.70B

CME earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-222.99 USD2.91 USD+2.7%Beat
2026-04-223.36 USD3.34 USD+0.6%Beat
2026-02-042.77 USD2.75 USD+0.7%Beat
2025-10-222.68 USD2.63 USD+1.9%Beat
2025-07-232.96 USD2.91 USD+1.7%Beat
2025-02-122.52 USD2.46 USD+2.4%Beat
2024-07-242.56 USD2.53 USD+1.2%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

CME valuation and analyst view

Trailing P/E21.03
Trailing EPS11.867 USD
Price / book3.38
Dividend yield4.51%
Market cap90.91B
Analyst consensusHold (15 buy / 17 hold / 5 sell)
Avg price target311.57 USD

Related research pages

Frequently asked questions

When is CME Group (CME)'s next earnings date?

CME Group is next scheduled to report on 2026-10-28, with a consensus EPS estimate of 2.93 USD and revenue estimate of 1.70B.

Did CME beat earnings last quarter?

In its 2026-07-22 report, CME posted EPS of 2.99 USD versus a 2.91 USD estimate — a beat of 2.7%.

What is CME's earnings track record?

Over the last 7 reported quarters with consensus data, CME beat estimates 7 times (100%).

What is CME's current P/E ratio and EPS?

CME trades at a trailing P/E of 21.03 on trailing EPS of 11.866779628060721 USD.

What do analysts rate CME?

Analyst consensus is "Hold" across 37 ratings (0 strong buy, 15 buy, 17 hold, 5 sell, 0 strong sell). Average 12-month price target: 311.57 USD.